Neanderthal genes and Nobel Prize in a popular lecture at Bioscience

An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...

Study: An objective diagnosis of constant tinnitus may be possible

A new method that measures brain activity during sound stimulation can make it possible to objectively diagnose and identify people who suffer from constant tin...

“An entire industry is about to be wiped out”

According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.

Göran Stiernstedt: “We are the world’s worst at continuity”

Failed investments in primary care, an unreasonable system with online doctors and a public failure at coordinating the healthcare IT system. Göran Stiernstedt ...

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

Norrländsk life science går för högtryck

Pharma Outsourcing igång på Stockholm Waterfront

Likviderar bolag

Aqilion lägger ner projektbolag efter klinisk studie.

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

Pengaregn över hälsoprojekt

22 projekt inom läkemedel, medtech och e-hälsa delar på 20,5 miljoner i Vinnova-utlysning.

Column: Repurposing as a golden ticket to approval

"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark...

Drug development creates new challenges for regulators

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

Adenovir får Vinnovastöd

Pengarna ska gå till att ta fram en uppföljare till bolagets kandidat mot epidemiskt keratokonjunktivit.

Adenovir Pharma klarar säkerhetsstudie

Ny läkemedelskandidat mot virusorsakad ögoninfektion visade sig väl tolererad av patienter i färsk studie.

Adenovir går in i fas II

Tar läkemedelskandidaten mot ögonsjukdom till nästa nivå.

New diagnostic test soon ready for the market

Adenovir tar in tio miljoner

Nu ska Puls-bolaget fullfölja sin fas II-studie och förbereda exit.

De fick pengar för djurfri forskning

Forska utan djurförsök tillkännager 2018 års anslag.

Vill motverka förfalskningar

Forskningssamarbetet Smedpack har valts ut som ett gott exempel i det treåriga Horizon 2020-projektet RRI-Tools.

Adenovir startar ny infektionsstudie

Går in i fas II med sin läkemedelskandidat mot den smittsamma ögonsjukdomen EKC.

Will the industry follow the economic revival?

Welcome to the eleventh Biotech Forum + Scanlab Fair!

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...

They’re all doing it – buying drug research

December 12 the time has come for this year's annual partnering meeting Pharma Outsourcing in Stockholm. In Sweden this is a growing business, with Recipharm as...